Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Gyre Therapeutics (GYRE) Tax Rate (2022 - 2026)

Gyre Therapeutics has reported Tax Rate over the past 7 years, most recently at 12.23% for Q4 2025.

  • Quarterly Tax Rate rose 26478.0% to 12.23% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 109.11% through Dec 2025, down 13783.0% year-over-year, with the annual reading at 109.11% for FY2025, 13783.0% down from the prior year.
  • Tax Rate was 12.23% for Q4 2025 at Gyre Therapeutics, down from 22.19% in the prior quarter.
  • Over five years, Tax Rate peaked at 35.6% in Q2 2023 and troughed at 277.01% in Q4 2024.
  • The 4-year median for Tax Rate is 22.19% (2025), against an average of 5.18%.
  • Year-over-year, Tax Rate crashed -27631bps in 2024 and then soared 26478bps in 2025.
  • A 4-year view of Tax Rate shows it stood at 22.36% in 2022, then skyrocketed by 97bps to 0.7% in 2023, then tumbled by -39640bps to 277.01% in 2024, then soared by 96bps to 12.23% in 2025.
  • Per Business Quant, the three most recent readings for GYRE's Tax Rate are 12.23% (Q4 2025), 22.19% (Q3 2025), and 29.58% (Q2 2025).